Philip J. Johnson

Also affiliated with Morpho (United States), Virginia Commonwealth University, Missouri College, Health Innovations (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma”.

Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma

Journal of Hepatology(2021)10.1016/j.jhep.2021.05.015

N/A

1.1DataRank · unranked

24 citations

Sarah Berhane, Harry Potts, Edward H. Williams, James Tanner, Tobias Janowitz +3 more

Chronic hepatitis in horses with persistent equine hepacivirus infection

Equine Veterinary Journal(2025)10.1111/evj.70124

N/A

0DataRank · unranked

6 citations

Daniela Luethy, Samantha Shallop, Jessica Cathcart, Thomas J. Divers, Jean‐Yin Tan +9 more